lead plaintiff

Super Micro Computer faces class action lawsuits following DOJ indictment of three individuals for allegedly diverting $2.5B in AI servers to China, causing 33% stock plunge.

Apollo Global Management faces securities fraud lawsuit over undisclosed Epstein ties. Stock fell 16% during class period; investors have until May 1, 2026 to file.

Rosen Law Firm filed securities class action against Trip.com over alleged false statements on regulatory risks. Investors have until May 11, 2026 to become lead plaintiffs.

Class action lawsuit filed against $LU alleging securities fraud, false statements, and inadequate internal controls. Investors urged to join case before May 2026 deadline.

Gemini Space Station faces securities fraud class action over alleged IPO prospectus misstatements. Stock plummeted 79% from $28 IPO price to $5.96 amid executive departures and restructuring.

Lufax faces securities class action lawsuit alleging disclosure violations and fraud. Investors with losses can seek lead plaintiff status by May 20, 2026.

New Era Energy & Digital faces securities class action lawsuit alleging CEO and former CFO certified false statements about Texas data center project and undisclosed fraud scheme.

Trip.com faces class action lawsuit alleging failure to disclose regulatory risks tied to monopolistic practices. Investors have until May 11, 2026 to join.

Class action lawsuit filed against Alight alleges executives made false statements on growth targets and capital returns. Investors who bought shares November 2024-February 2026 may be eligible; lead plaintiff deadline May 15, 2026.

Rosen Law Firm files securities class action against Upstart Holdings ($UPST) over false AI model claims, with lead plaintiff deadline June 8, 2026.

Rosen Law Firm urges $PSIX investors to join securities class action lawsuit before May 19, 2026 deadline. Eligible shareholders may recover losses from alleged securities violations.

Class action lawsuit filed against Lufax Holding Ltd alleging securities fraud and inadequate internal controls from April 2023 through January 2025.

Shareholders sue Atara Biotherapeutics for allegedly misleading statements on manufacturing issues and failed ALLELE study data affecting tabelecleucel approval prospects.

The Gross Law Firm filed a securities lawsuit against United Homes Group, alleging controlling shareholder Nieri made false statements while orchestrating a forced sale.

Medpace faces class action suit alleging false guidance on cancellation rates. Stock plunged 15.9% after Q4 2025 miss, triggering investor claims.

The Gross Law Firm filed a class action lawsuit against Ostin Technology Group, alleging materially false statements and stock price manipulation through registered offerings.

Stellantis shareholders can file claims by June 8, 2026, in lawsuit alleging false earnings statements and concealed EV adoption risks that triggered stock collapse.

Corcept Therapeutics ($CORT) faces securities lawsuit over alleged false FDA statements on relacorilant. Lead plaintiff deadline: April 21, 2026.

Law firm urges Coty shareholders with losses to join class action alleging false statements about market conditions and segment performance. Deadline to become lead plaintiff: May 22, 2026.

Rosen Law Firm files securities class action against Medpace Holdings for alleged false statements regarding business metrics and financial performance, urging investors to act before deadline.